FDA issued a Warning Letter to CGA Limited on 12/19/2019 as a result of this inspection.
483 CGA May 2019$119 - Not in Stock
FDA investigators audited the CGA - Laventille, Trinidad & Tobago facility and issued inspectional observations (via FDA 483) on 31 May 2019.
- Category: Human Drugs
- Inspection end: 31 May 2019
- Location: Laventille, Trinidad & Tobago
- FEI: 3008527957
Pre-Order Not Available